JP2015180638A5 - - Google Patents

Download PDF

Info

Publication number
JP2015180638A5
JP2015180638A5 JP2015093123A JP2015093123A JP2015180638A5 JP 2015180638 A5 JP2015180638 A5 JP 2015180638A5 JP 2015093123 A JP2015093123 A JP 2015093123A JP 2015093123 A JP2015093123 A JP 2015093123A JP 2015180638 A5 JP2015180638 A5 JP 2015180638A5
Authority
JP
Japan
Prior art keywords
leishmania
pharmaceutical composition
extract
ribosomal
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015093123A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015180638A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2015180638A publication Critical patent/JP2015180638A/ja
Publication of JP2015180638A5 publication Critical patent/JP2015180638A5/ja
Pending legal-status Critical Current

Links

JP2015093123A 2008-01-18 2015-04-30 リボソームタンパク質抽出物（ＲＰＥ）及び場合によってＴｈ１促進アジュバントを含むワクチン Pending JP2015180638A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US2192808P 2008-01-18 2008-01-18
EP08100634.8 2008-01-18
US61/021,928 2008-01-18
EP08100634 2008-01-18

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2010542611A Division JP2011509968A (ja) 2008-01-18 2009-01-14 リボソームタンパク質抽出物（ＲＰＥ）及び場合によってＴｈ１促進アジュバントを含むワクチン

Publications (2)

Publication Number Publication Date
JP2015180638A JP2015180638A (ja) 2015-10-15
JP2015180638A5 true JP2015180638A5 (enExample) 2016-02-18

Family

ID=39471089

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010542611A Pending JP2011509968A (ja) 2008-01-18 2009-01-14 リボソームタンパク質抽出物（ＲＰＥ）及び場合によってＴｈ１促進アジュバントを含むワクチン
JP2015093123A Pending JP2015180638A (ja) 2008-01-18 2015-04-30 リボソームタンパク質抽出物（ＲＰＥ）及び場合によってＴｈ１促進アジュバントを含むワクチン

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2010542611A Pending JP2011509968A (ja) 2008-01-18 2009-01-14 リボソームタンパク質抽出物（ＲＰＥ）及び場合によってＴｈ１促進アジュバントを含むワクチン

Country Status (19)

Country Link
US (1) US20110020405A1 (enExample)
EP (2) EP2231700B1 (enExample)
JP (2) JP2011509968A (enExample)
CN (1) CN101977930B (enExample)
AP (1) AP3007A (enExample)
AU (1) AU2009204849B2 (enExample)
BR (1) BRPI0906787A2 (enExample)
CA (1) CA2712475A1 (enExample)
CO (1) CO6280495A2 (enExample)
DK (1) DK2231700T3 (enExample)
ES (1) ES2486365T3 (enExample)
HR (1) HRP20140447T1 (enExample)
MA (1) MA32080B1 (enExample)
MX (1) MX2010007831A (enExample)
PL (1) PL2231700T3 (enExample)
PT (1) PT2231700E (enExample)
RU (1) RU2521499C2 (enExample)
WO (1) WO2009090175A1 (enExample)
ZA (1) ZA201005143B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SA110310855B1 (ar) 2009-11-13 2014-09-16 Laboratories Leti S L Unipersonal استخدام مصدر l3 و/ أو l5 كلقاح أو كوسيلة تشخيصية لمرض طفيلي
SG190222A1 (en) 2010-11-10 2013-06-28 Leti Sl Lab New adjuvant

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6500437B1 (en) * 1995-09-22 2002-12-31 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
PT1141305E (pt) * 1998-12-23 2006-10-31 Leti Lab Gene quimerico formado pelas sequencias de adn que codifica os determinantes antigenicos de quatro proteinas de l. infantum
ES2169995B1 (es) * 2000-04-17 2003-12-01 Leti Lab Composicion a base de la proteina lip2a y su uso en la preparacion de un medicamento para suscitar una respuesta inmune contra un antigeno.
US20030072714A1 (en) * 2001-10-12 2003-04-17 Magill Alan J. Microfluidized leishmania lysate and methods of making and using thereof

Similar Documents

Publication Publication Date Title
CN106659777A8 (zh) 免疫原性组合产品
WO2015142671A3 (en) Influenza virus vectors and uses therefor
EP4043031A3 (en) Zika viral antigen constructs
WO2015095249A8 (en) Single chain il-12 nucleic acids, polypeptids, and uses thereof
IL276210B2 (en) Mers-cov vaccine
EP4667485A3 (en) A vaccine for use in the prophylaxis and/or treatment of a disease
WO2012177924A3 (en) Influenza virus mutants and uses therefor
WO2016073955A3 (en) Cells lacking b2m surface expression and methods for allogeneic administration of such cells
WO2014018858A3 (en) Multimeric fusion protein vaccine and immunotherapeutic
JP2014534202A5 (enExample)
JP2014051497A5 (enExample)
JP2017035093A5 (enExample)
EP4632075A3 (en) Method for reducing immunogenicity of rna
MY187459A (en) Vaccine compositions
WO2017041100A3 (en) Vaccine compositions having improved stability and immunogenicity
WO2017015463A3 (en) Infectious disease vaccines
JP2017048194A5 (enExample)
WO2016029187A3 (en) Process for producing oxygenated products of valencene
WO2006113214A3 (en) Vaccine against pandemic strains of influenza viruses
WO2017027757A3 (en) Smallpox vaccine for use in cancer treatment
EA201892735A1 (ru) Состав вакцины против hiv
WO2016073595A8 (en) T cells and dendritic cells for polyomavirus therapy
FI3220937T3 (fi) Pneumolysiinimutantteja ja menetelmiä niiden käyttämiseksi
RU2018116601A (ru) Иммунногенный слитый белок
WO2016168214A3 (en) Immunogenic fusion proteins for the treatment of cancer